脑膜炎奈瑟菌的候选蛋白质疫苗
摘要
脑膜炎奈瑟菌是引起脑膜炎、菌血症等侵袭性疾病的重要病原菌，也可以无症状的鼻咽部带菌状态存在。分为13个血清群，但只有6个群（A，B，C，W-135，Y和X）与其致病性有关。目前应用的疫苗主要是荚膜多糖疫苗和多糖蛋白结合疫苗。两者本质上都属荚膜多糖抗原，覆盖的血清群有限，无法做到对B群脑膜炎奈瑟菌的预防，因此发展通用蛋白质疫苗势在必行。能作为候选疫苗的具有免疫原性的蛋白质需具备以下特点：在大多数菌株中都表达且结构保守；可诱生杀菌抗体或保护性抗体。
出处
《实用医学杂志》
CAS
2008年第20期3613-3615,共3页
The Journal of Practical Medicine
参考文献13
-
1Tondella M L, Popovic T, Rosenstein N E, et al. Distribution of Neisseria meningitidis serogroup B serosubtypes and serotypes circulating in the United States [J]. J Clin Microbiol, 2000,38(9) :3323-3328.
-
2van der Ende A, Hopman C T, Keijzers W C, et al. Outbreak of meningococcal disease caused by PorA-defieient meningococci [J]. J Infect Dis,2003,187 (5) :869-871.
-
3Moe G R, Zuno-Mitchell P, Lee S S, et al. Functional activity of anti-neisserial surface protein A monoclonal antibodies against strains of Neisseria meningitidis serogroup B [J]. Infect Immun, 2001,69 (6) :3762-3771.
-
4Scott A H, Langley J M, Smith B, et al. Phase 1 first-in-human studies of the reactogenicity and immunogenicity of a recombinant meningococcal NspA vaccine in healthy adults [J]. Vaccine, 2007,25 (3) :450-457.
-
5Madico G, Welsch J A, Lewis L A, et al. The meningococcal vaccine candidate GNA 1 870 binds the complement regulatory protein factor H and enhances serum resistance [J]. J Immunol,2006, 177( 1 ) :501-510.
-
6Giuliani M M, Santini L, Brunelli B, et al.The region comprising amino acids 100 to 255 of neisseria meningitides lipoprotein GNA 1870 elicits bactericidal antibodies [J]. Infect Immun, 2005,73 (2):3762- 3771.
-
7Capecchi B, Adu-Bobie J, Marcello F D, et al. Neisseria meningitides NadA is a new invasin which promotes bacterial adhesion to and penetration intohuman epithelial cells [J]. Molecular Microbiology,2005,55 (3) : 687-698.
-
8Comanducci M, Bambini S, Brunelli B. NadA, a novel vaccine candidate of Neisscria meningitides [J]. J Exp Med, 2002,11 (3) : 1445-1454.
-
9Jacobsson S, Thulin S ,Molling P, et al. Sequence constancies and variations in genes encoding three new meningococcal vaccine candidate antigens [J]. Vaccine, 2006, 24(12) :2161-2168.
-
10Welsch J A, Moe G R, Rossi R, et al. Antibody to genome-derived neisserial antigen 2 132, a Neisseria meningitidis candidate vaccine, confers protection against bacteremia in absence of complement-mediated bactericidal activity [J]. J Infect Dis, 2003,188 ( 11 ) : 1730- 1740.
-
1亓晓,赵根明,姜庆玉.肺炎链球菌疫苗的研究进展[J].国外医学（微生物学分册）,2004,27(1):25-28.
-
2林涛.类风湿关节炎的主要症状和治疗药物的合理应用[J].黑龙江医药,2014,27(4):910-913. 被引量：5
-
3薛新娜,陈茶.肺炎链球菌疫苗的研究进展[J].现代检验医学杂志,2010,25(3):127-130. 被引量：10
-
4陈锦华,何小燕,李康,赵立新.显色法鉴别念珠菌属阴道感染与带菌状态探讨[J].中华医院感染学杂志,2006,16(9):1074-1074.
-
5陈许,孙仁华,韩芳,黄瑾.老年慢性阻塞性肺疾病患者淋巴细胞对肺炎链球菌荚膜多糖的反应能力[J].中国老年学杂志,2013,33(12):2767-2769.
-
6曹炬（综述）,尹一兵（审校）.肺炎链球菌蛋白质疫苗研究进展[J].国际检验医学杂志,2007,28(3):214-216. 被引量：3
-
7于丽华（综述）,沈叙庄（审校）.B族链球菌疫苗的研究进展[J].国际儿科学杂志,2007,34(1):43-46. 被引量：9
-
8张世勇,高秋菊.肺炎球菌疫苗免疫婴儿的血清可保护小鼠免受6A和6B型肺炎球菌的侵袭性感染[J].国外医学（预防．诊断．治疗用生物制品分册）,2001,24(6):273-273.
-
9李潇.抗疟疾的合成蛋白质疫苗[J].中国生物化学与分子生物学报,2002,18(1):119-119.
-
10王海文.肺炎链球菌疫苗最新研究进展[J].医学信息（下旬刊）,2011,24(6):406-406. 被引量：7
